Status:
COMPLETED
Improving Cervical Cancer Screening in Women Living With HIV Attending Chronic Disease Clinics in Semi-rural Tanzania
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Krebsforschung Schweiz, Bern, Switzerland
Abviris Deutschland GmbH
Conditions:
Cervical Cancer Screening
Eligibility:
FEMALE
18-65 years
Brief Summary
This study is to analyse the effect of a bundle of measures on the proportion of females being screened for cervical cancer in the Kilombero and Ulanga Antiretroviral Cohort (KIULARCO), comparing the ...
Detailed Description
Cervical cancer (CC) is the most common cancer among women living with HIV (WLWH) and the leading cause of cancer-related death in women in East Africa. Currently there are around 2800 WLWH in care at...
Eligibility Criteria
Inclusion
- WLWH enrolled in KIULARCO, who are at least 3 months on Anti-Retroviral Treatment (ART)
- 18-65 years of age
- Non-pregnant (reported)
- Signed informed consent
Exclusion
- Pregnancy
- Known invasive cervical cancer
- Any condition interfering with visualization of the cervix
Key Trial Info
Start Date :
July 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 18 2024
Estimated Enrollment :
2974 Patients enrolled
Trial Details
Trial ID
NCT05256862
Start Date
July 27 2021
End Date
October 18 2024
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Francis Referral Hospital, Ifakara Health Institute (IHI, United Republic of Tanzania)
Ifakara, Tanzania